Product Information
TICAGRELOR 60 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3032 per EA under NDC 00378221491. Its NADAC has been published 43 times since Oct 29, 2025.
FDA first approved this application on Jul 9, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Ticagrelor market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
60 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378221491
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TICAGRELORApproval Type
Generic (ANDA)
FDA Application
ANDA208597FDA Approved
7/9/2021
TE Code
AB
On Market Since
9/25/2025
Pharmacological Classes
Price Statistics
The NADAC for TICAGRELOR 60 MG TABLET has been published 43 times since Oct 29, 2025, and over the history we have for it it has declined 94.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3032 per EA |
|---|---|
| All-time high | $5.9399 (Nov 12, 2025) |
| All-time low | $0.3032 (Aug 19, 2026) |
| 52-week high | $5.9399 |
| 52-week low | $0.3032 |
| Median price | $0.6197 |
| Average price | $2.4319 |
| Largest weekly change | -73.8% (Mar 18, 2026) |
| Weeks tracked | 43 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TICAGRELOR 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TICAGRELOR 60 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.3032 per EA (NDC 00378221491), effective Aug 19, 2026.
How has the price of TICAGRELOR 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for TICAGRELOR 60 MG TABLET has declined 94.9%. It has been tracked across 43 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for TICAGRELOR 60 MG TABLET?
Since Oct 29, 2025, the NADAC for TICAGRELOR 60 MG TABLET has ranged from a low of $0.3032 (Aug 19, 2026) to a high of $5.9399 (Nov 12, 2025), with a median of $0.6197 per EA.
Are there cheaper alternatives to TICAGRELOR 60 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TICAGRELOR 60 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TICAGRELOR 60 MG TABLET?
TICAGRELOR 60 MG TABLET (NDC 00378221491) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.